What Global Health Diplomacy Can Teach Israel and Somaliland
Health as Statecraft: What Global Health Diplomacy Can Teach Israel and Somaliland
Public health diplomacy sits where humanitarian action meets foreign policy. A vaccine shipment, laboratory partnership, or training program can save lives while building trust between governments. Unlike military cooperation, health initiatives offer tangible civilian benefits. But goodwill is not automatic: it depends on equitable access, reliable delivery, and lasting local capacity.
The experience of global vaccine diplomacy offers useful lessons for a potential Israel–Somaliland health partnership, particularly around the Somaliland Center for Disease Control (SL-CDC) and a National Public Health Laboratory in Hargeisa.
Why health belongs in foreign policy.
Health cooperation can advance several diplomatic goals at once. Programs such as the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and Cuba’s overseas medical missions illustrate how sustained care can become a source of international visibility and goodwill.
It also serves mutual self-interest. Pathogens cross borders, so stronger surveillance and diagnostic systems abroad can help countries detect emerging threats earlier. Cooperation on outbreak response, laboratory standards, and information sharing supports both public health and economic continuity.
Health can also keep dialogue alive when political relations are strained. U.S.–Soviet cooperation against smallpox remains a powerful example of adversaries working toward a shared objective. Yet medical assistance should not be treated simply as leverage: partnerships lose credibility when patients’ needs appear secondary to geopolitical bargaining.
Finally, health diplomacy shapes trade and governance. Cross-border health standards can reduce disruption, while technology-transfer negotiations and international health rules influence who has access to essential tools. The strongest partnerships connect these strategic interests to measurable public benefit.
Vaccine diplomacy: three contrasting approaches
COVID-19 exposed both the promise and the limits of health as statecraft. The United States, China, and Russia pursued different combinations of domestic protection, international assistance, and strategic messaging.
United States: Washington initially prioritized domestic vaccination before expanding international donations through COVAX and partnerships such as the Quad. Its later contribution highlighted biomedical innovation and multilateral cooperation. The diplomatic lesson is that strong technology matters, but delayed access can undermine solidarity and encourage partners to seek alternative suppliers.
China: Beijing’s Health Silk Road combined vaccine sales, donations, and manufacturing partnerships. Early availability gave China an opening when many lower-income countries struggled to obtain supplies. Local production arrangements offered potential longer-term ties, although questions about protection against emerging variants complicated the reputational benefits.
Russia: Sputnik V was promoted as evidence of scientific strength and an alternative to Western suppliers. However, manufacturing constraints, delivery delays, and regulatory concerns weakened that promise. The Ukraine war and sanctions further complicated international cooperation.
The takeaway is broader than a contest between countries or vaccine platforms. Speed, clinical performance, transparency, and dependable supply all shape credibility. Announcing support can generate headlines; delivering usable products and strengthening local systems are what sustain trust. Health diplomacy works best when political ambition stays within operational capacity.
The Israel–Somaliland opportunity
For Israel and Somaliland, cooperation around an SL-CDC and national laboratory could turn diplomatic interest into practical institution-building. The opportunity should be assessed through confirmed commitments and public health outcomes, rather than assuming that proposed facilities or partnerships are already operational.
Four priorities would make such cooperation more durable:
- Build institutions, not just announcements. Clear responsibilities, sustainable financing, laboratory quality systems, and training would give cooperation an operational foundation beyond summits and political statements.
- Put civilian benefits first. Better diagnostics, outbreak response, and maternal and child health services could demonstrate the partnership’s value to communities. Humanitarian credibility depends on those benefits being accessible and not subordinated to security messaging.
- Support shared health security. Surveillance linked to the Gulf of Aden and Berbera trade corridor could help identify risks affecting people, livestock, and commerce. Any information-sharing arrangements should protect privacy and clarify how data will be used.
- Strengthen local ownership. Fellowships and technical exchanges should build Somaliland’s ability to run and maintain its own systems. Greater administrative capacity can support international engagement, but a health institution does not itself settle questions of diplomatic recognition.
The bottom line
Health diplomacy is most persuasive when it produces dependable services rather than symbolic gestures. An Israel–Somaliland partnership could create lasting value by combining technical expertise with locally defined needs and accountable governance. Its success should be judged by stronger institutions, earlier detection, and better care—not by geopolitical messaging alone.